Hormone Receptor and HER2 Status in Breast Cancer Patients: What Does It Mean?

Hormone Receptor and HER2 Status in Breast Cancer Patients: What Does It Mean?

If you have been diagnosed with breast cancer, it is almost decided that the surgeon will ask for a biopsy. During a biopsy, a sample of the cancer-affected tissue is taken for pathological analysis. A biopsy can be conducted before surgery or during surgery for breast cancer removal.

The pathological report tells you the hormone receptor status. That is, it tells you whether the cancer cells in your breast possess receptors that are sensitive to the two hormones, estrogen, and progesterone. The receptors are actually proteins present on the surface of the cells that identify the triggers and accordingly signal the cells to grow.

In the case of breast cancer, hormone receptors, if present, pick up hormone signals and tell the cells to grow. These receptors are present in normal breast cells and some types of breast cancer cells as well.

blog-detail

Explore popular Destinations, Best Hospitals and experienced Doctors

Explore

Hormone receptors are of the following two types:

Hormone-Receptor-and-HER2-Status-in-Breast-Cancer-Patients

  • ER-positive cells: These are the breast cancer cells that have estrogen receptors and hence called ER-positive. According to WebMD, it is reported in almost 80 percent of all breast cancers.
  • PR-positive cells: These are the breast cancer cells that have progesterone receptors and hence called PR-positive. According to WebMD, it is reported in almost 60 percent of all breast cancers.

Breast cancer cells may have just ER-positive or PR-positive cells or both. Apart from hormone receptor status, there is something called HER-2 positive or negative breast cancer. HER2 is actually a protein made by cells in the breast. Nearly 20 percent of the breast cancer cells make this protein, and such a cancer is characterized as fast-growing or aggressive. Such cancers are almost always treated with the help of specific drugs along with chemotherapy after the surgery.

This article talks about some of the important things that you must know about the hormone receptor.

Importance of Knowing Hormone Status During Breast Cancer Treatment

Immunohistochemistry (IHC) is the most common test used to check or confirm the presence of receptor cells in the breast cancer tissue retrieved during a biopsy. The most important reason why knowing hormone receptor status is that the cancer treatment plan prepared by the oncologists will depend on the kind of cells that you possess. It helps them make the best treatment decisions, based on the type, extent, spread, and hormone receptor status of your cancer.

A tumor is regarded as hormone-receptor-positive if at least one percent of the cells that are pathologically tested possess estrogen or progesterone receptors. If the concentration is less than one percent, the cells are treated as hormone-receptor-negative.

The hormone receptor status of the breast cancer cells clears the picture for the oncologists. For example, hormone-receptor-positive cancer grows slowly and women with this type of cancer have a better short-term outlook. On the other hand, hormone-receptor-negative cancers grow quickly and faster than hormone-positive cells and cancer relapse, if it happens, happens in the initial few years after the first treatment.

Additionally, ER/PR-positive tumors are more likely to respond to hormone therapy as compared to ER/PR-negative tumors. There are different types of medications and drugs available for hormone therapy. These drugs work by blocking the hormonal receptors or lowering the levels of estrogen in the body. These may include tamoxifen and class of drugs known as aromatase inhibitors and CDK 4/6 inhibitors.

blog-detail

Know Everything about Breast Cancer - Symptoms, Recovery and Treatment

Know More

Breast Cancer HER2 Status

HER2, a growth-promoting protein, is present on the surface of all breast cells. However, some breast cancer cells may possess a higher than normal concentration of this protein. Such cancer cells are known as HER2-positive. Such cancers are more likely to spread quickly and aggressively.

It is important to know the HER-2 status of cancer in women who have been diagnosed with invasive breast cancer. This is because such cancers are more likely to be benefited from the use of drugs that target the HER2 protein.

A Fluorescent in situ hybridization (FISH) or IHC, conducted at the time of biopsy testing, confirm whether the cancer is HER2-positive or not. In case the result is 0 or 1+, the cancer is regarded as HER2-negative. Such cancers do not respond to drugs that target the HER2 protein. If the result is 3+, the cancer is HER-2 positive and respond well to drugs that target this protein. The HER2 status is not clear and further testing is required if the result is +2.

Triple-negative Versus Triple-positive Breast Cancer

Triple-negative breast cancers to do not too much of HER2 protein. Additionally, they do not possess ER and PR hormone receptors. This type of cancer is more common in African-American and Hispanic women, in addition to younger women.

Triple-negative breast cancers are more likely to spread quicker than any other type of breast cancer. In addition, treatment is a bit tricky. Because the protein and the hormone receptors are absent, specific drugs cannot be used to target HER2 protein or block ER/PR hormone receptors. Therefore, such patients are treated with the help of drugs most suitable for chemotherapy.

Triple-positive breast cancers have too much of HER2 and also possess ER/PR hormone receptors. The drugs that target HER2 can be used for the treatment of women who have triple-positive breast cancer. Additionally, drugs that block ER/PR hormone receptors can also be used for their treatment.

blog-detail

Looking for Breast Cancer Treatment Plan?

Get Help from Experts

Other Links: Breast Cancer Treatment starting from USD4000

Breast Cancer Awareness Month: Types, treatments, and costs

Some of The Best Hospitals Providing Breast Cancer Treatment Worl-Wide

Zulekha Hospital Sharjah

Sharjah,United Arab Emirates

  • ISO 9001
  • Joint Commission International, or JCI

In the year 1992 with the noble vision of Dr Zulekha Daud who shifted her base from India to Sharjah in order to serve people who are in need at an affordable cost, Zulekha Healthcare Group was established. She later established a hospital in Dubai too and Zulekha Dubai is now true to its mission of serving the suffering and the ailing. It is a multidisciplinary hospital with advanced diagnostic centres and well-equipped pharmacies. In the year 2004 the Dubai hospital saw its inception. It h... Read More

103

PROCEDURES

11

DOCTORS in 10 Specialties

6+

Facilities & Amenities

Right to quality healthcare is a vision in which Sarvodaya hospital in Faridabad believes and this is how they have embarked upon their journey. Since 1991, they have been slowly adding to their capacities and incorporating latest technologies to ensure no time or money is lost without a purpose to detect a disease and bring about its eradication. They had also launched several courses in their institute to train motivated individuals who can bring about a change in the way the sy... Read More

143

PROCEDURES

22

DOCTORS in 14 Specialties

6+

Facilities & Amenities

2+

Reviews

Fortis Hospital

Bengaluru,India

  • ISO 9001
  • National Accreditation Board for Hospitals & Healthcare Providers (NABH)

Among hospitals in Bangalore one of the leading healthcare delivery providers is Fortis Bangalore. It has secured number 2 position in terms of being equipped with the latest technology and being one of the most advanced hospitals in the world. Their 24x7 emergency services and pharmacy services enfold their customers with a sense of security that the duty of health care is now in trusted hands. Not only some of the best doctors and surgeons man the hospital but there are numerous talented v... Read More

132

PROCEDURES

32

DOCTORS in 12 Specialties

6+

Facilities & Amenities

  • Joint Commission International, or JCI
  • National Accreditation Board for Hospitals & Healthcare Providers (NABH)

First of its kind in South India, Apollo hospital in Bangalore is a delineated name among the Apollo chain of Hospitals. It is proud to have the state of the art armamentarium equipped with the right technologies under a single roof. After undergoing an extensive process of assessments the medical experts and doctors have been selected who have undergone trainings in international medical bodies around the world.

Apollo hospital Bangalore review shows that 99.6% is their success rate... Read More

111

PROCEDURES

38

DOCTORS in 13 Specialties

6+

Facilities & Amenities

Zulekha Hospital Dubai

Dubai,United Arab Emirates

4.7

2 Reviews

  • ISO 9001
  • Joint Commission International, or JCI

In the year 1992 with the noble vision of Dr. Zulekha Daud who shifted her base from India to Sharjah in order to serve people who are in need at an affordable cost, Zulekha Healthcare Group was established. She later established a hospital in Dubai too and Zulekha Dubai is now true to its mission of serving the suffering and the ailing. It is a multidisciplinary hospital with advanced diagnostic centers and well-equipped pharmacies. In the year 2004, the Dubai hospital saw its inception. It... Read More

100

PROCEDURES

13

DOCTORS in 10 Specialties

6+

Facilities & Amenities

2+

Reviews

Consult with the Best Oncologist Over a Video Call Across the the World

Ertugrul Gazioglu

General Laparoscopic Surgeon,...

Istanbul, Turkey


Book @ USD 300

Emel Ceylan Gunay

Radiation Oncologist

Istanbul, Turkey


Book @ USD 300

Voratape Kijtavee

Surgical Oncologist

Bangkok, Thailand


Book @ USD 175

Amit Bhargava

Medical Oncologist

New Delhi, India


Book @ USD 45

Valerijus Ostapenko

Surgical Oncologist

Vilnius, Lithuania


Book @ USD 300

Mohammed Salhab

Medical Oncologist

Denver, United States


Book @ USD 650

Last modified on at Apr 11, 2022

Guneet Bhatia

Guneet Bhatia is an avid reader, healthcare writer, and is currently Director of Patient Care Department, MediGence. She has also been featured on many prominent Healthcare portals such as IBTimes, HCIT Expert, Clinician Today.

Recent Post

Our Success Stories

Our team of healthcare experts would be happy to assist you

Get In Touch
or call

(+1) 424 283 4838